This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Should You Buy the Dip in Marijuana ETFs Ahead of Earnings?
by Sanghamitra Saha
Hexo's downbeat results weigh on marijuana space but many key pot companies are likely to beat in November. This could provide a good entry points to pot ETFs.
Top and Flop ETFs of October
by Sanghamitra Saha
Signs of some progress in the U.S.-China trade relation, Brexit doldrums, oil price rally and mixed earnings pulled the stings of the market movement and made these ETFs winners and losers.
One More Marijuana ETF on the Block
by Sanghamitra Saha
As Global X launches a fresh pot ETF, let's explore the product in detail.
Worst Sector ETFs of August
by Sanghamitra Saha
August was trade-war trodden and dealt a blow to the broader equity market. These sector ETFs were among the most-hurt ones.
HubSpot, Kraft Heinz, CNBS, Canopy Growth, Aurora Cannabis and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
HubSpot, Kraft Heinz, CNBS, Canopy Growth, Aurora Cannabis and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF
by Neena Mishra
CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.
Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF
by Neena Mishra
CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.
ETFs in Focus as Consolidation Drives Marijuana Industry
by Sanghamitra Saha
Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.